Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 7/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22815942 | 0.89 | CYP19A1 (0.45) | CYP19A1SMN1; SMN2POLBMAPTRXFP1 | |
| SCHEMBL22815919 | 0.89 | ALOX15 (0.43) | POLBMAPTRXFP1ALOX15L3MBTL1 | |
| SCHEMBL22816960 | 0.83 | POLB (0.40) | CYP19A1SMN1; SMN2POLBMAPTRXFP1 | |
| SCHEMBL22816959 | 0.83 | CYP19A1 (0.43) | CYP19A1SMN1; SMN2POLBMAPTRXFP1 | |
| SCHEMBL23484488 | 0.83 | PTGDR2 (0.46) | CYP19A1SMN1; SMN2POLBMAPTRXFP1 | |
| SCHEMBL22816922 | 0.81 | PTGDR2 (0.45) | CYP19A1SMN1; SMN2POLBMAPTRXFP1 | |
| SCHEMBL1412428 | 0.80 | CYP19A1 (0.54) | CYP19A1SMN1; SMN2POLBMAPTRXFP1 | |
| SCHEMBL22816008 | 0.80 | CYP19A1 (0.46) | CYP19A1SMN1; SMN2POLBMAPTRXFP1 | |
| SCHEMBL22815992 | 0.80 | CYP19A1 (0.44) | CYP19A1SMN1; SMN2POLBMAPTRXFP1 | |
| SCHEMBL22816961 | 0.80 | ALOX15 (0.42) | POLBMAPTRXFP1ALOX15L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11384055-B2 | Glycolate oxidase inhibitors for the treatment of disease | BIOMARIN PHARMACEUTICAL INC. (US) | 2022-07-12 | — | — | US | disclosed |
| WO-2020257487-A1 | GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARMACEUTICAL INC. (US) | 2020-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11384055-B2 | Glycolate oxidase inhibitors for the treatment of disease | XDH, PNPO, AGXT | CYP19A1 1433/4885SMN1; SMN2 2118/4885POLB 870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.